BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 11001576)

  • 1. Radiofrequency hyperthermia in the palliative treatment of mucinous carcinomatosis of appendiceal origin: optimizing and monitoring heat delivery in western patients.
    Sugarbaker PH; Sugarbaker C; Stephens AD; Chang D
    Int J Hyperthermia; 2000; 16(5):429-41. PubMed ID: 11001576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
    Lord AC; Shihab O; Chandrakumaran K; Mohamed F; Cecil TD; Moran BJ
    Eur J Surg Oncol; 2015 Mar; 41(3):396-9. PubMed ID: 25216980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix.
    Sparks DS; Morris B; Xu W; Fulton J; Atkinson V; Meade B; Lutton N
    Int Surg; 2015 Jan; 100(1):21-8. PubMed ID: 25594636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
    Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL
    Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appendiceal cancer and peritoneal carcinomatosis: a report of 29 cases.
    Esquivel J; Merriman B; Davis S; Manning D
    Am Surg; 2006 Aug; 72(8):714-7; discussion 717-8. PubMed ID: 16913315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms.
    Austin F; Mavanur A; Sathaiah M; Steel J; Lenzner D; Ramalingam L; Holtzman M; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
    Ann Surg Oncol; 2012 May; 19(5):1386-93. PubMed ID: 22302270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucinous tumor of the appendix with limited peritoneal spread: is there a role for expectant observation?
    Zih FS; Wong-Chong N; Hummel C; Petronis J; Panzarella T; Pollett A; McCart JA; Swallow CJ
    Ann Surg Oncol; 2014 Jan; 21(1):225-31. PubMed ID: 24100959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms.
    Bijelic L; Yan TD; Sugarbaker PH
    J Surg Oncol; 2008 Sep; 98(4):295-9. PubMed ID: 18726900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal Dissemination.
    Huang Y; Alzahrani NA; Chua TC; Morris DL
    Dis Colon Rectum; 2017 Apr; 60(4):360-367. PubMed ID: 28267002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
    El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A
    Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection.
    Grotz TE; Overman MJ; Eng C; Raghav KP; Royal RE; Mansfield PF; Mann GN; Robinson KA; Beaty KA; Rafeeq S; Matamoros A; Taggart MW; Fournier KF
    Ann Surg Oncol; 2017 Sep; 24(9):2646-2654. PubMed ID: 28695394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of an inguinal hernia in patients with pseudomyxoma peritonei.
    Sugarbaker PH
    Eur J Surg Oncol; 2017 Jun; 43(6):1083-1087. PubMed ID: 28131668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasis.
    Foster JM; Sleightholm RL; Wahlmeier S; Loggie B; Sharma P; Patel A
    World J Surg Oncol; 2016 Sep; 14(1):243. PubMed ID: 27619776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
    Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal and appendiceal origin].
    Berger Y; Zbar AP; Lebedyev A; Levi Y; Nevler A; Aderka D; Golan T; Purim O; Brenner B; Natur M; Gutman M
    Harefuah; 2014 Jun; 153(6):315-9, 368. PubMed ID: 25095601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
    Sugarbaker PH; Alderman R; Edwards G; Marquardt CE; Gushchin V; Esquivel J; Chang D
    Ann Surg Oncol; 2006 May; 13(5):635-44. PubMed ID: 16523363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does obesity affect outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for disseminated mucinous appendiceal neoplasms?
    Polanco PM; Sanchez AI; Ramalingam L; Jones H; Zureikat A; Holtzman M; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
    Ann Surg Oncol; 2014 Nov; 21(12):3963-9. PubMed ID: 24916747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
    Ihemelandu C; Mavros MN; Sugarbaker P
    Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive surgical history prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with poor survival outcomes in patients with peritoneal mucinous carcinomatosis of appendiceal origin.
    Milovanov V; Sardi A; Aydin N; Nieroda C; Sittig M; Nunez M; Gushchin V
    Eur J Surg Oncol; 2015 Jul; 41(7):881-5. PubMed ID: 25899982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.